Yale New Haven Hospital Stroke Center Quality Report (2017)

Yale New Haven Hospital aims to provide the highest quality of stroke care using national standard performance measures. This report shows the percent of patients who receive these treatments compared to patients at other Connecticut hospitals and U.S. primary stroke centers in the country. * Our goal is a 95-98% or greater with each measure.

99%-100% = stretch target

95%-98% = met target

< 95% = below target

 

 

Performance measure

YNHH

Other CT hospitals

Other primary stroke centers

 

Venous thrombus embolism (VTE)
Treatment to prevent blood clots from forming when confined to bed

 

95.9%

 

96.6%

 

97.9%

 

Discharged on anti-thrombotic therapy
Going home on a blood thinner to prevent another ischemic stroke

 

99.6%

 

99.7%

 

99.4%

 

Anti-coagulation for atrial fibrillation/flutter
Treated with a strong blood thinner when you have an abnormal heart rhythm that could cause blood clots

 

99.0%

 

97.2%

 

97.1%

 

Thrombolytic therapy
Arriving to the hospital within 2 hours of stroke symptoms and treated with a clot-busting drug within 3 hours of symptoms

 

81.3%

 

88.0%

 

92.0%

 

Anti-thrombotics by hospital day #2
Treated with a blood thinner within two days after admission to prevent further strokes

 

93.5%

 

95.6%

 

98.0%

 

Discharged on a statin medication
Treated with a cholesterol-lowering drug to reduce your stroke risk

 

96.4%

 

97.4%

 

98.1%

 

Stroke education
Provided with information about warning signs, stroke risk factors, and the importance of calling 9-1-1

 

96.2%

 

96.9%

 

96.8%

 

Assessed for rehabilitation
Evaluated by a member of the rehabilitation team to assess your need for recovery therapy

 

98.7%

 

99.2%

 

99.3%

*This information is based on data retrieved from Outcomes Science Get With The Guidelines® database

Yale New Haven Hospital Stroke Center Outcomes Report (2017)

Yale New Haven Hospital’s stroke program monitors outcomes for selected ischemic stroke patients who undergo emergency neuro-interventions.

Of the stroke patients at YNHH treated by IV with the clot-dissolver alteplase, 5.4% of patients had complications from receiving IV alteplase, compared to the national average complication rate of 6%.

In 2017, 139 emergency thrombectomy procedures were performed at YNHH. More than three-quarters (77%) of patients had meaningful improvement of blood flow to their brain. More than two-thirds (72%) of patients were discharged to home or a rehabilitation center.